The ODAC Chronicles: Part 4. Hurdles pre and post accelerated approval.
Grillo-López
Antonio J
AJ
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D017598:Efficiency, Organizational; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents